SJ Medical
SJ Medical
India has emerged as one of the world's most critical markets and manufacturing hubs for Drug-Eluting Stents (DES). With the rising prevalence of cardiovascular diseases (CVD) across both urban and rural demographics, the demand for advanced interventional cardiology tools has seen exponential growth. As a leading manufacturer and exporter, we recognize that the Indian healthcare sector requires a balance of high-end innovation and cost-effective scalability.
Our commitment to the Indian market involves providing stents that feature Sirolimus-eluting technologies with bio-compatible or polymer-free coatings. These advancements are crucial in reducing late stent thrombosis (LST) and ensuring faster endothelialization, which is a primary concern for Indian cardiologists treating complex coronary artery diseases.
Sqm Production Facility
Global Export Countries
Patents & Certifications
Years of Expertise
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
Traditional DES used permanent polymers to control drug release, which occasionally triggered inflammatory responses. In India, the trend is shifting toward Polymer-Free Stent Systems. These use micro-porous surface structures to hold the drug (like Sirolimus) directly on the stent strut, eliminating the long-term risks associated with polymer degradation.
Indian patients often present with smaller vessel diameters. Our R&D focuses on ultra-thin Cobalt-Chromium (CoCr) struts that provide exceptional radial strength while maintaining a low profile for easier delivery through tortuous Indian anatomies.
With the implementation of the National Pharmaceutical Pricing Authority (NPPA) price caps on stents in India, manufacturers must innovate to provide premium quality at regulated prices. We leverage high-scale manufacturing and lean supply chains to support Indian distributors and hospitals without compromising on clinical safety.
Our Drug-Eluting Stents are widely utilized in major medical hubs across India, including:
These stents are essential for Percutaneous Coronary Interventions (PCI) in patients suffering from multi-vessel disease, diabetes-related coronary complications, and acute myocardial infarction.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
Our Equipment: We utilize precision balloon forming equipment, laser welding, and marking technologies, ensuring every stent exported to India meets international benchmarks.
Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We understand the regulatory hurdles of the CDSCO in India and provide full documentation support for seamless import and distribution.
